Eledon Pharmaceuticals (ELDN) Accounts Payables (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Accounts Payables of $6.6 million for Q1 2026, up 81.56% on a QoQ basis from $3.6 million in Q4 2025, and up 126.99% year-over-year from $2.9 million in Q1 2025.
Eledon Pharmaceuticals (ELDN) Accounts Payables (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Accounts Payables history runs 14 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- Quarterly Accounts Payables rose 126.99% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (up 126.99% YoY) and the FY2025 annual result came in at $3.6 million, down 37.82% from the prior year.
- Accounts Payables was $6.6 million for Q1 2026 at Eledon Pharmaceuticals, up from $3.6 million in the prior quarter.
- Across five years, Accounts Payables topped out at $6.6 million in Q1 2026 and bottomed at $465000.0 in Q3 2023.
- A 5-year average of $3.2 million and a median of $2.9 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables slumped 87.95% — and 2024, when it surged 1160.22%.
- Eledon Pharmaceuticals' Accounts Payables stood at $2.2 million in 2022, then tumbled by 56.05% to $967000.0 in 2023, then jumped by 503.21% to $5.8 million in 2024, then slumped by 37.82% to $3.6 million in 2025, then surged by 81.56% to $6.6 million in 2026.
- Business Quant data shows ELDN's Accounts Payables at $6.6 million in Q1 2026, $3.6 million in Q4 2025, and $4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Eledon Pharmaceuticals | 404.17 Mn | 404.17 Mn | - | 6.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.59 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 967,000.00 |
| Sep 30, 2023 | 465,000.00 |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.81 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 857,000.00 |